Curative Biotechnology

Curative Biotechnology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Curative Biotechnology (CUBT) as of Oct 11, 2026 is -1.50 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -2.44 M USD — a change of -38.47% (higher).

EBITDA

-1.50 MUSD

YoY

-38.47%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Curative Biotechnology is 2025 -1.50 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Curative Biotechnology was 2024 -2.44 M USD. It decreases by -38.47% higher compared to the previous year.

The Curative Biotechnology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-5,451.00 USD
Jan 1, 2019
-151.00 USD
Jan 1, 2020
-4.60 M USD
Jan 1, 2021
-5.16 M USD
Jan 1, 2022
-4.46 M USD
Jan 1, 2023
-1.93 M USD
Jan 1, 2024
-2.44 M USD
Jan 1, 2025
-1.50 M USD
The Curative Biotechnology EBITDA history
YEAREBITDAYoY
-1.50 MUSD-38.47%
-2.44 MUSD+26.28%
-1.93 MUSD-56.68%
-4.46 MUSD-13.47%
-5.16 MUSD+12.15%
-4.60 MUSD+3.04 M%
-151.00USD-97.23%
-5,451.00USD-23.24%
-7,101.00USD+367.79%
-1,518.00USD-98.26%
-87,150.00USD+77.69%
-49,045.00USD—
Access this data via the Eulerpool API
Get Free API Key

Curative Biotechnology Stock analysis

What does Curative Biotechnology do? Curative Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curative Biotechnology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Curative Biotechnology is -1.50 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Curative Biotechnology changed from -2.44 M USD to -1.50 M USD, representing a -38.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Curative Biotechnology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Curative Biotechnology historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Curative Biotechnology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Curative Biotechnology